MedPage Today on MSN
Similar prostate cancer drugs show different results in real-world study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.
Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.
Relief for men experiencing the challenges of Benign Prostatic Hyperplasia (BPH), or prostate enlargement, has arrived with the introduction of Flowel and Flowel Plus by Superior Pharmaceuticals ...
A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the best to prescribe upfront—and to which patients. Over the past 14 years, ...
In following with the younger Romo’s post-playing career, the father-son duo are providing “play-by-play” style commentary on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results